Biotechnology is the application of biological organisms, cells, biological molecules or biological processes to develop products, technologies and useful processes. The field combines biology with engineering, chemistry, medicine, agriculture, environmental science and computational methods. Traditional biotechnology includes processes such as fermentation and selective breeding, while modern biotechnology includes recombinant DNA technology, genome sequencing, cell culture, genetic engineering, synthetic biology and bioprocess engineering. Biotechnology can use whole organisms, isolated enzymes, cultured cells, nucleic acids or other biological components. The central principle is that biological systems possess specialised capabilities that can be understood, controlled or adapted for useful purposes. Biotechnology therefore includes both ancient biological practices and highly sophisticated modern technologies operating at molecular and cellular scales.
Traditional biotechnology predates modern molecular biology by thousands of years. Humans have used microorganisms in fermentation to produce bread, yoghurt, cheese, vinegar and alcoholic beverages, while selective breeding has changed the characteristics of domesticated plants and animals. These processes used biological mechanisms without requiring knowledge of DNA or genes. Modern biotechnology expanded dramatically after discoveries concerning heredity, DNA structure, molecular genetics and recombinant DNA methods.
The ability to isolate, copy and modify genetic material allowed researchers to produce biological molecules in organisms that would not naturally make them. Biotechnology consequently developed from largely empirical biological practices into a discipline capable of deliberately manipulating molecular and cellular processes according to defined objectives.
Medical biotechnology includes the development of vaccines, diagnostic tests, therapeutic proteins, gene therapies, cell therapies and other biomedical technologies. Recombinant DNA methods allow microorganisms or cultured cells to produce proteins used as medicines. Monoclonal antibodies can be engineered or selected to bind specific molecular targets and are used for diagnosis and treatment. Nucleic acid amplification and sequencing technologies enable sensitive detection and characterisation of infectious agents and genetic variants.
Cell based therapies use living cells as therapeutic agents, while gene therapies seek to modify genetic material or its expression to treat particular diseases. Biotechnology has therefore transformed the relationship between biological research and medicine by allowing molecular discoveries to be converted into practical diagnostic and therapeutic tools.
Agricultural biotechnology applies biological knowledge to crops, livestock and agricultural systems. Conventional breeding remains important, while molecular markers, genomic selection, tissue culture and genetic engineering can accelerate or modify particular breeding strategies. Genetically modified organisms may contain introduced, altered or otherwise modified genetic material designed to provide traits such as pest resistance or altered composition. Other biotechnology applications include microbial production of agricultural inputs, plant disease diagnostics and development of improved propagation methods. Biotechnology can potentially improve yield, nutritional characteristics, stress tolerance or resource efficiency, but outcomes depend on the specific organism, trait, environment and management system. Genetic modification is therefore one component of agricultural biotechnology rather than a synonym for the entire field.
Industrial biotechnology uses microorganisms, enzymes and cells to manufacture chemicals, materials, fuels, foods and other products. Fermentation systems can cultivate microorganisms under controlled conditions, while purified enzymes can catalyse industrial reactions with high specificity. Biotechnology can produce organic acids, amino acids, enzymes, vitamins, bioactive compounds and specialised materials. Bioreactors control variables such as temperature, pH, oxygen concentration, nutrient availability and agitation to create suitable conditions for biological production. Downstream processing then separates and purifies the desired product. Biological manufacturing can sometimes operate under milder conditions than conventional chemical synthesis and can use renewable feedstocks, although environmental benefits depend on energy use, feedstock sourcing, waste generation and the complete production system.
Environmental biotechnology applies biological processes to pollution control, waste treatment and resource recovery. Microorganisms can degrade or transform certain organic pollutants, and engineered or selected microbial communities are central to many wastewater treatment processes. Anaerobic digestion uses microbial communities to break down organic material and can produce biogas. Bioremediation uses organisms or biological processes to reduce contamination in soil, water or other environments. Biotechnology can also contribute to biosensors, environmental monitoring and recovery of valuable substances from waste streams. The effectiveness of environmental biotechnology depends on pollutant chemistry, microbial ecology, temperature, oxygen availability, nutrient conditions and site characteristics. Biological treatment is therefore not universally applicable but can be highly effective when the relevant biological pathways and environmental conditions are suitable.
Modern biotechnology increasingly uses genomic and computational approaches. Genome sequencing reveals the genetic potential of organisms, while transcriptomics, proteomics and metabolomics examine RNA, proteins and small molecule metabolites. Synthetic biology combines molecular biology with engineering principles to design biological systems with specified functions. Gene editing can modify DNA with increasing precision, while automated laboratory systems can screen large numbers of biological variants. Bioinformatics is essential for analysing the enormous datasets generated by modern biotechnology. Artificial intelligence and machine learning can assist protein structure prediction, sequence analysis, biological design and process optimisation, although computational predictions require experimental validation. The integration of biological and digital technologies is expanding the range of organisms and processes that can be investigated and engineered.
Biotechnology has limitations and requires careful consideration of safety, regulation, ethics and environmental consequences. Biological systems can behave unpredictably when moved into new contexts because genes and organisms interact with complex environments. Production processes may encounter contamination, genetic instability, variable yields or difficulties in scaling from laboratory experiments to industrial manufacture. Some biotechnology applications raise questions about ecological effects, animal welfare, genetic privacy, access to treatments and responsible use of genetic technologies.
Regulatory requirements vary according to the product and jurisdiction and may address safety, environmental release, manufacturing quality and clinical effectiveness. Biotechnology is therefore not simply the use of advanced laboratory tools. It is a broad technological field in which biological knowledge is translated into practical systems, products and processes, with applications extending from food production and environmental management to medicine, manufacturing and fundamental research.
